VIB and V-Bio Ventures have both participated in a series A round for Muna Therapeutics, the result of a merger of two recent spinouts.

Muna Therapeutics, a Denmark-based developer of treatments for neurodegenerative diseases, closed a $73m series A round today backed by VIB and its venture capital affiliate V-Bio Ventures. Pharmaceutical firm Novo, Sofinnova Partners, Droia Ventures and LSP Dementia co-led the round, with additional participation from Sanofi Ventures, the strategic investment arm of pharmaceutical firm Sanofi, Polaris…

The rest of this content is only accessible to University Venturing: News, Data, and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.